Fingerprint
Dive into the research topics of 'Incidence of late relapses in patients with HER2-positive breast cancer receiving adjuvant trastuzumab: Combined analysis of NCCTG N9831 (Alliance) and NRG oncology/NSABP B-31'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically